Cargando…
Brain Metastases From Differentiated Thyroid Carcinoma: Prevalence, Current Therapies, and Outcomes
BACKGROUND AND OBJECTIVE: The brain is an unusual site for distant metastases of differentiated thyroid carcinoma (DTC). The aim of this study was to document the prevalence of brain metastases from DTC at our institutions and to analyze the current therapies and the outcomes of these patients. METH...
Autores principales: | Gomes-Lima, Cristiane J, Wu, Di, Rao, Sarika N, Punukollu, Sree, Hritani, Rama, Zeymo, Alexander, Deeb, Hala, Mete, Mihriye, Aulisi, Edward F, Van Nostrand, Douglas, Jonklaas, Jacqueline, Wartofsky, Leonard, Burman, Kenneth D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348752/ https://www.ncbi.nlm.nih.gov/pubmed/30706042 http://dx.doi.org/10.1210/js.2018-00241 |
Ejemplares similares
-
Efficacy of Dosimetric Versus Empiric Prescribed Activity of (131)I for Therapy of Differentiated Thyroid Cancer
por: Klubo-Gwiezdzinska, Joanna, et al.
Publicado: (2011) -
MON-556 Sex-Bias in Clinicopathological Presentation of Patients with Differentiated Thyroid Cancer
por: Shobab, Leila, et al.
Publicado: (2019) -
Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for (131)I Administration
por: Gomes-Lima, Cristiane J, et al.
Publicado: (2022) -
Response to Letter to the Editor from Zandee and Links: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for (131)I Administration”
por: Gomes-Lima, Cristiane J, et al.
Publicado: (2023) -
MON-551 Immediate Cause Of Death In Patients With Thyroid Cancer Progression
por: Ylli, Dorina, et al.
Publicado: (2019)